Alx Oncology Holdings Inc.
About
1.90USD+0.01 +0.53%
Closed • Updated at 06:58 GMT+00:00Market Cap$255.67M
Volume704.8K
Beta0.68
RSI48.31
Alx Oncology Holdings Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 8 2026
ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update
Apr 30 2026
ALX Oncology Announces That CD47 Biomarker Data from Clinical Trial Evaluating Evorpacept + Zanidatamab Combination in Advanced Breast Cancer Will Be Presented at ESMO Breast Cancer 2026
Apr 17 2026
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
Apr 13 2026
ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer
Feb 27 2026
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Community Chat
Ask AI
Try asking